跳至主要内容
临床试验/NCT06068335
NCT06068335招募中不适用

Innate Immunity in Allergic Asthma

University of Central Florida1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年10月18日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
To determine which parameters of the established type-2 signature obtained in vitro is significantly different between healthy controls, allergic individuals, and asthmatic individuals ex vivo.

研究概览

简要总结

The purpose of this study is to determine whether a potential type 2 signature, obtained through stimulation of cell lines with various allergens in vitro, correlates with an allergic or asthmatic disease state ex vivo. This type 2 signature will be multi-hierarchical in nature and will be comprised cell surface receptor expression, pathway activation, and gene upregulation.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants must be at least 18 years of age
  • no history of allergic disease (healthy controls), have clinically diagnosed allergies, or have clinically diagnosed asthma.

排除标准

  • Pregnant women and prisoners will be excluded from the study.
  • Individuals currently suffering from any acute infections and those known to suffer from light-headedness will be excluded.

结局指标

主要结局

To determine which parameters of the established type-2 signature obtained in vitro is significantly different between healthy controls, allergic individuals, and asthmatic individuals ex vivo.

时间窗: 1 year

次要结局

  • To determine ex vivo whether any of the identified disease-specific type-2 parameters can be modified (brought back to healthy control levels) through the use of investigational compounds.(1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Innate Immunity in Allergic Asthma | 临床试验